Pharma Reviews: Grapevine: KKR leads race for Piramal pharma stake; Glaxo looks to sell HUL holding

KKR has previously invested in at least two Indian pharmaceutical companies—Slayback Pharma and Gland Pharma Ltd. The PE firm had put in $60 ...
Read more: Grapevine: KKR leads race for Piramal pharma stake; Glaxo looks to sell HUL holding